I
Overview
Innovative Hematology is a nonprofit hematology care and research organization. It provides multidisciplinary care, education, research, and support for people with bleeding, clotting, and other blood disorders. Its programs serve patients, families, clinicians, researchers, and community partners involved in complex hematologic conditions. The organization brings physicians, nurses, pharmacists, social workers, laboratory and research teams, educators, and administrators into coordinated programs. Work spans clinical care, nursing, pharmacy, social work, research, laboratory, education, patient support, and administration.
Work here?Claim your company
Simplify's take
What believers are saying
- The March 26, 2026 WANE feature broadened regional awareness of on-site gene therapy.
- Innovative Hematology launched a research publications library on November 5, 2026.
- Ahuja’s April 1, 2026 CEO role supports disciplined expansion and payer coordination.
What critics are saying
- Heavy dependence on one high-cost gene therapy workflow exposes reimbursement and utilization pressure.
- Indianapolis concentration limits growth if out-of-state referrals fail to offset local demand.
- A disappointing hemophilia gene therapy adoption curve leaves the hub underutilized and economically fragile.
What makes Innovative Hematology unique
- Indiana’s only comprehensive on-site hemophilia gene therapy hub launched February 5, 2026.
- Twenty hematologists and multidisciplinary clinicians centralize rare-disease care at Naab Road, Indianapolis.
- CEO Sanjay Ahuja and Chief Clinical Officer Amy Shapiro preserve continuity across the 2026 transition.
Help us improve and share your feedback! Did you find this helpful?